Chester County News and Community Website
TELA Bio, Inc. (Nasdaq: TELA), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.
MALVERN, PA — TELA Bio Inc. (NASDAQ: TELA) will present at the Canaccord Genuity 46th Annual Growth Conference on Aug. 12, providing investors with an update as the medical technology …
TELA Bio to Present at Canaccord Growth Conference Read More MALVERN, PA — TELA Bio Inc. (NASDAQ: TELA) will report second-quarter 2026 financial results on Aug. 10 and provide investors with a business update as the medical technology company continues …
TELA Bio Sets Aug. 10 Earnings Call and Business Update Read More MALVERN, PA — TELA Bio, Inc. (Nasdaq: TELA) reported modest first-quarter revenue growth as accelerating European sales helped offset slower product mix trends in the United States.
TELA Bio Expands Europe Sales as U.S. Growth Slows Read More MALVERN, PA — TELA Bio (Nasdaq: TELA) granted restricted stock units covering 89,250 shares to 12 newly hired employees as the medical device maker continues expanding its commercial operations and …
TELA Bio Expands Workforce With Nasdaq Equity Grants Read More MALVERN, PA — TELA Bio, Inc. (Nasdaq: TELA) said it will replace four of its seven directors following its June 9 annual meeting and reported preliminary first-quarter revenue above prior …
TELA Bio Plans Board Overhaul, Reports Preliminary Q1 Revenue Beat Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) will report its first-quarter 2026 financial results on Tuesday, May 12, 2026, and will host a conference call and webcast at 4:30 …
TELA Bio Schedules Q1 2026 Earnings Release and Call Read More MALVERN, PA — TELA Bio Inc. (NASDAQ: TELA) said it will report financial results for the fourth quarter and full year ended December 31, 2025, on Tuesday, March 24, 2026.
TELA Bio to Report Fourth Quarter and Full-Year 2025 Results March 24 Read More MALVERN, PA — TELA Bio Inc. (NASDAQ: TELA) announced that its board’s Compensation Committee approved inducement grants of restricted stock units covering 8,550 shares of common stock to three newly …
TELA Bio Grants Inducement RSUs to New Employees Read More MALVERN, PA — TELA Bio (NASDAQ: TELA) has approved inducement equity awards for five newly hired employees, signaling continued investment in talent as the medical technology company advances its commercial-stage …
TELA Bio Grants Equity to New Hires as Medtech Growth Push Continues Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has issued equity awards to newly hired staff, a move that reflects continued investment in talent as the medical technology company advances …
TELA Bio Signals Growth With New-Hire Equity Grants Read More